mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
1e-05 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-05 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-05 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
6e-05 |